HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer

SCLC at advanced stage is considered an incurable disease. Despite good response to initial chemotherapy, the responses in SCLC patients with metastatic disease are of short duration and resistance inevitably occurs. Although several target-specific drugs have altered the paradigm of treatment for m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lai, Chien-Hao, Park, Kang-Seo, Lee, Dae-Hao, Alberobello, Anna Teresa, Raffeld, Mark, Pierobon, Mariaelena, Pin, Elisa, Petricoin, Emanuel F., Wang, Yisong, Giaccone, Giuseppe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002667/
https://ncbi.nlm.nih.gov/pubmed/24166505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2013.439
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak